# LegitScript Website Remediation Summary

**Project:** MedMethod Direct  
**Scope:** LegitScript Question 44 website feedback  
**Status:** Explicit website corrections implemented; one ambiguous site-description item remains pending clarification.

## Completed Corrections

| Audit concern | Completed remediation |
|---|---|
| Temporarily unpublish `/male` | The route, page, redirect, footer link, and male-only components were removed in the prior compliance checkpoint. |
| Temporarily unpublish the semaglutide-versus-tirzepatide article | Removed the article route registration, source module, blog listing, sitemap entry, public `llms.txt` reference, and 72 links from location pages. The URL now renders the not-found page. |
| Remove compounded-versus-brand pricing comparisons | Replaced the homepage and landing-page comparison sections with neutral medication-cost and fulfillment guidance. Removed the comparison-based `/pricing-guide` route and source page. |
| Remove brand-name equivalence framing | Removed “same active ingredient,” lower-cost alternative, and Wegovy/Zepbound equivalence language. Medication selection is now described as individualized and based on clinical needs, pharmacy availability, insurance, and expected costs. |
| Add clear compounded-medication context | Key patient-facing landing pages now state that compounded medications are not FDA-approved and that FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. |
| Remove quantified testimonials and outcome claims | Removed hardcoded testimonial sections from the main and legacy homepage routes and from 87 location pages. Deleted the two shared testimonial components. |
| Remove “Just results” | Replaced the slogan with neutral physician-led care language. |
| Clean repeated location-page copy | Updated repeated telehealth, treatment-response, compounded-medication, insurance, and pharmacy-fulfillment FAQ answers across 104 location-page files. |

## Route Verification

| Route | Verified result |
|---|---|
| `/` | Renders with neutral medication-cost guidance and no outcome testimonials. |
| `/lp/hrt3` | Renders with neutral medication counseling and no outcome testimonials. |
| `/lp/hrt2` | Renders with a single individualized medication-review explanation and no comparison cards. |
| `/lp/WL` | Renders with neutral prescription-review and fulfillment guidance. |
| `/lp/WL2` | Renders with medication-cost variability and the compounded-medication disclosure. |
| `/blog/semaglutide-vs-tirzepatide-women-midlife` | Renders the not-found page. |
| `/pricing-guide` | Renders the not-found page. |

## Quality Controls

The project now includes `server/legitScriptCompliance.test.ts`, which prevents the flagged article, comparison pricing page, hardcoded location testimonials, and explicitly prohibited phrases from being reintroduced. TypeScript validation, all 113 tests, the production build, visual route checks, and runtime-log review passed after remediation.

## Pending Clarification

The audit’s final site-description or metadata note was not specific enough to identify a required replacement. No change was made to that ambiguous item. MedMethod Direct should ask LegitScript to provide the exact field, URL, and requested wording before modifying it.
